Jack L Bowman - Net Worth and Insider Trading
Jack L Bowman Net Worth
The estimated net worth of Jack L Bowman is at least $3 Million dollars as of 2024-09-20. Jack L Bowman is the Director of Celgene Corp and owns about 24,000 shares of Celgene Corp (CELG) stock worth over $3 Million. Jack L Bowman is also the Director of Sarepta Therapeutics Inc and owns about 833 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $105,874. Details can be seen in Jack L Bowman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jack L Bowman has not made any transactions after 2007-05-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jack L Bowman
Jack L Bowman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jack L Bowman owns 5 companies in total, including Sarepta Therapeutics Inc (SRPT) , Armata Pharmaceuticals Inc (ARMP) , and CTI BioPharma Corp (CTIC) among others .
Click here to see the complete history of Jack L Bowman’s form 4 insider trades.
Insider Ownership Summary of Jack L Bowman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2006-03-17 | director |
| ARMP | Armata Pharmaceuticals Inc | 2004-05-20 | director |
| CTIC | CTI BioPharma Corp | 2004-04-21 | director |
 | | 2003-11-10 | director |
| | 2003-08-08 | director |
Jack L Bowman Latest Holdings Summary
Jack L Bowman currently owns a total of 2 stocks. Among these stocks, Jack L Bowman owns 24,000 shares of Celgene Corp (CELG) as of May 7, 2007, with a value of $3 Million and a weighting of 96.08%. Jack L Bowman also owns 833 shares of Sarepta Therapeutics Inc (SRPT) as of March 17, 2006, with a value of $105,874 and a weighting of 3.92%.
Latest Holdings of Jack L Bowman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CELG | Celgene Corp | 2007-05-07 | 24,000 | 108.24 | 2,597,760 |
| SRPT | Sarepta Therapeutics Inc | 2006-03-17 | 833 | 127.10 | 105,874 |
Holding Weightings of Jack L Bowman
Jack L Bowman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jack L Bowman has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 80,000 shares on May 7, 2007, which brought Jack L Bowman around $3 Million.
According to the SEC Form 4 filings, Jack L Bowman has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 833 shares on March 17, 2006, which cost Jack L Bowman around $31,800.
Insider Trading History of Jack L Bowman
- 1
Jack L Bowman Trading Performance
GuruFocus tracks the stock performance after each of Jack L Bowman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jack L Bowman is -38.64%. GuruFocus also compares Jack L Bowman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jack L Bowman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jack L Bowman's insider trading performs compared to the benchmark.
Performance of Jack L Bowman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.68 | | | | | |
| Relative Return to S&P 500(%) | 7.36 | | | | | |
Jack L Bowman Ownership Network
Jack L Bowman Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Jack L Bowman is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Jack L Bowman made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .
In summary, during the past 3 months, insiders sold 56,699 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net sale of 19,661 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Jack L Bowman Mailing Address
Above is the net worth, insider trading, and ownership report for Jack L Bowman. You might contact Jack L Bowman via mailing address: 3102 Mt Vista Avenue, Lummi Island Wa 98262.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
